Location History:
- Willowdale, CA (1996 - 2006)
- Ontario, CA (2010)
- Toronto, CA (1998 - 2022)
Company Filing History:
Years Active: 1996-2022
Title: The Innovative Work of Inventor Johanna Rommens
Introduction:
Johanna Rommens is a renowned inventor based in Toronto, CA, known for her pioneering work in the field of genetic modifications associated with various diseases. With a total of 19 patents to her name, Rommens has significantly contributed to advancements in personalized medicine and treatment methodologies.
Latest Patents:
1. Modifiers of CFTR-directed therapy: Rommens' patent revolves around a genetic modifier of cystic fibrosis (CF), which can predict the effectiveness of CFTR-directed therapy. By identifying specific SNPs in non-coding regions of SLC26A9, correlations with CF lung disease severity and patient response to therapies like Ivacaftor have been established. This innovation provides a breakthrough in predicting treatment efficacy and patient selection for CFTR-directed therapeutics.
2. Genes from 20q13 amplicon and their uses: This patent focuses on cDNA sequences from a region on chromosome 20 linked to diseases. The identified sequences are instrumental in detecting chromosomal abnormalities associated with various disorders and offer potential for disease treatment.
Career Highlights:
Johanna Rommens has made significant contributions working at prestigious institutions such as The Hospital for Sick Children and the University of California. Her career highlights include groundbreaking research in genetic modifiers and disease-associated gene sequences, leading to the development of novel treatment methodologies for complex diseases.
Collaborations:
Throughout her career, Rommens has collaborated with esteemed professionals in the field, including Joe W Gray and Colin Conrad Collins. These collaborations have fostered innovative research endeavors and propelled advancements in the field of genetics and personalized medicine.
Conclusion:
Inventor Johanna Rommens' dedication to advancements in genetic modifiers and disease treatment strategies has left a lasting impact on the field of personalized medicine. Her patents and collaborations stand as a testament to her innovative spirit and commitment to improving healthcare outcomes for individuals affected by complex diseases.